-
Published13/02/2025
-
Today15/03/2025
-
Deadline19/03/2025
-
Opening of tenders19/03/2025
Utilities
- indicates text translated automatically in your browsing language
Drug supply - Active substance vedolizumab - ATC L04AG05 Text automatically translated in your browsing language Automatically translated
The subject of the contract is the continuous supply of a medicinal product containing the active substance vedolizumab – ATC L04AG05. pharmaceutical form 300MG INF PLV CSL 1, unit of measurement 1 x 300MG, quantity 400 pharmaceutical form 108MG INJ SOL PEP 1X0.68ML, unit of measurement 1 x 108MG, quantity 2 400 Text automatically translated in your browsing language Automatically translated
https://www.egordion.cz/nabidkaGORDION/profilTN
https://www.egordion.cz/nabidkaGORDION/profilTN
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.